HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid productsJanuary 17, 2024
Clinical Criteria updates — September 2023
On September 21, 2023, and October 4, 2023, the Pharmacy and Therapeutic (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for HealthKeepers, Inc. These policies were developed, revised, or reviewed to support clinical coding edits.
Visit Clinical Criteria to search for specific policies. For questions or additional information, use this email.
Please see the explanation/definition for each category of Clinical Criteria below:
- New: Newly published criteria
- Revised: Addition or removal of medical necessity requirements, new document number
- Updates Marked with an asterisk (*) notate that the criteria may be perceived as more restrictive
Please share this notice with other providers in your practice and office staff.
Please note:
- The Clinical Criteria listed below applies only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.
- This notice is meant to inform the provider of new or revised criteria that has been adopted by HealthKeepers, Inc. only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.
Effective date | Clinical Criteria number | Clinical Criteria title | New or revised |
February 25, 2024 | *CC-0248 | Elrexfio (elranatamab-bcmm) | New |
February 25, 2024 | *CC-0249 | Talvey (talquetamab-tgvs) | New |
February 25, 2024 | *CC-0250 | Veopoz (pozelimab-bbfg) | New |
February 25, 2024 | *CC-0251 | Ycanth (cantharidin) | New |
February 25, 2024 | *CC-0018 | Pompe Disease | Revised |
February 25, 2024 | *CC-0021 | Fabrazyme (agalsidase beta) | Revised |
February 25, 2024 | *CC-0046 | Zinplava (bezlotoxumab) | Revised |
February 25, 2024 | CC-0182 | Iron Agents | Revised |
February 25, 2024 | *CC-0068 | Growth Hormones | Revised |
February 25, 2024 | CC-0156 | Reblozyl (luspatercept) | Revised |
February 25, 2024 | *CC-0233 | Rebyota (fecal microbiota, live – jslm) | Revised |
February 25, 2024 | *CC-0020 | Natalizumab Agents (Tysabri, Tyruko) | Revised |
February 25, 2024 | CC-0064 | Interleukin-1 Inhibitors | Revised |
February 25, 2024 | CC-0026 | Testosterone Injectable | Revised |
February 25, 2024 | *CC-0247 | Beyfortus (nirsevimab) | Revised |
HealthKeepers, Inc. is an independent licensee of the Blue Cross Blue Shield Association. Anthem HealthKeepers Plus, offered by HealthKeepers, Inc., is a health plan that contracts with the Virginia Department of Medical Assistance Services to provide Medicaid benefits to enrollees. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
VABCBS-CD-048721-23-CPN48226
PUBLICATIONS: February 2024 Provider Newsletter
To view this article online:
Or scan this QR code with your phone